Alzheimer’s drug development now targets tau, neuroinflammation, metabolism, and synaptic dysfunction — expanding beyond amyloid toward precision medicine and combination therapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/beyond-amyloid-whats-pipeline-alzheimers-2026a1000jzj?src=rss
Author :
Publish date : 2026-06-15 07:28:00
Copyright for syndicated content belongs to the linked Source.